Introduction
Lipocortin 1 (annexin 1) is a member of the annexin family of calcium-phospholipid binding proteins. 1'2 The production of lipocortin 1 is induced by glucocorticoids in a number of systems, s-6 including human peripheral blood mononuclear cells after in vivo exposure to glucocorticoids. 7 Lipocortin 1 has been demonstrated to have a number of anti-inflammatory actions in both in vitro and in vivo systems, sq6 but the influence of this protein on cytokine production is unknown. The anti-inflammatory activity of lipocortin 1 in vivo has yet to be fully explained in terms of specific actions.
Interleukin-1 (IL-1) is a potent pro-inflammatory cytokine which is produced in a wide range of tissues including tissue macrophages, peripheral blood monocytes, brain, synovium, lung, gut, and bone. 17 It is involved in the mediation of inflammation in a diverse list of conditions including rheumatoid arthritis. 18 Fig. 1 and 2 ).
Pretreatment of monocytes with neutralizing antibody to lipocortin 1 in doses of 0.5-50.0/g/ml had no effect on the inhibitory action of dexamethasone 10-7M on IL-I release (Fig. 1) .
Pretreatment of monocytes with rhLC1 2 x 10 -6 M had no suppressive effect on non-LPS treated monocyte IL-lfl release, nor on the increase in IL-I] release induced by LPS (Fig. 2) . Pretreatment of monocytes with the 1-188aa lipocortin 1 fragment at concentrations of 2 x 10 -SM to 2 x 10 -6 M similarly had no effect on untreated or LPS treated monocyte IL-lfl release (Fig. 3 ).
Discussion
Evidence 
